发明名称 Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
摘要 Dry powder formulations for inhalation comprising spray-dried particles and their use in the treatment of an obstructive or inflammatory airways disease. Each particle has a core of a first active ingredient in substantially crystalline form that is coated with a layer of a second active ingredient in substantially amorphous form that is dispersed in a pharmaceutically acceptable hydrophobic excipient. A process for preparing such formulations is also described.
申请公布号 US9050267(B2) 申请公布日期 2015.06.09
申请号 US201213982630 申请日期 2012.02.03
申请人 Novartis AG 发明人 Weers Jeffry G.;Rao Nagaraja;Huang Daniel;Miller Danforth;Tarara Thomas E.
分类号 A61K9/14;A61K9/50;A61K9/00;A61K45/06;A61K31/40;A61K31/4704;A61K31/56;A61K31/58;A61M15/00;A61K9/16 主分类号 A61K9/14
代理机构 代理人 Woods Daniel
主权项 1. A dry powder formulation for inhalation comprising spray-dried particles that comprise a core of a first active ingredient in substantially crystalline form that is coated with a layer of a second active ingredient in substantially amorphous form that is dispersed in a pharmaceutically acceptable hydrophobic excipient.
地址 Basel CH